These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24363251)

  • 21. Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises.
    Sanchez-Danes A; Benzoni P; Memo M; Dell'Era P; Raya A; Consiglio A
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1114-27. PubMed ID: 24040813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling long-QT syndromes with iPS cells.
    Sinnecker D; Goedel A; Dorn T; Dirschinger RJ; Moretti A; Laugwitz KL
    J Cardiovasc Transl Res; 2013 Feb; 6(1):31-6. PubMed ID: 23076501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species.
    Imamura M; Okuno H; Tomioka I; Kawamura Y; Lin ZY; Nakajima R; Akamatsu W; Okano HJ; Matsuzaki Y; Sasaki E; Okano H
    Methods Mol Biol; 2012; 925():21-48. PubMed ID: 22907488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induced pluripotent stem cell-based therapies for inherited arrhythmias: opportunities and challenges involved (Review).
    Li G; He X; Sun C
    Mol Med Rep; 2015 Jan; 11(1):3-10. PubMed ID: 25323841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives for induced pluripotent stem cell technology: new insights into human physiology involved in somatic mosaicism.
    Nagata N; Yamanaka S
    Circ Res; 2014 Jan; 114(3):505-10. PubMed ID: 24481841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QT hysteresis in long-QT syndrome children with exercise testing.
    Gao DS; Fang WY; Chiu-Man C; Kirsh J; Gross G; Hamilton RM
    Chin Med J (Engl); 2007 Feb; 120(3):179-82. PubMed ID: 17355817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing.
    Wang Y; Liang P; Lan F; Wu H; Lisowski L; Gu M; Hu S; Kay MA; Urnov FD; Shinnawi R; Gold JD; Gepstein L; Wu JC
    J Am Coll Cardiol; 2014 Aug; 64(5):451-9. PubMed ID: 25082577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
    Ito D; Okano H; Suzuki N
    Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells.
    Sala L; Gnecchi M; Schwartz PJ
    Arrhythm Electrophysiol Rev; 2019 May; 8(2):105-110. PubMed ID: 31114684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precision medicine for long QT syndrome: patient-specific iPSCs take the lead.
    Yu Y; Deschenes I; Zhao MT
    Expert Rev Mol Med; 2023 Jan; 25():e5. PubMed ID: 36597672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced pluripotent stem cells: an emerging theranostics platform.
    Nelson TJ; Terzic A
    Clin Pharmacol Ther; 2011 May; 89(5):648-50. PubMed ID: 21512525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors.
    Shafa M; Sjonnesen K; Yamashita A; Liu S; Michalak M; Kallos MS; Rancourt DE
    J Tissue Eng Regen Med; 2012 Jun; 6(6):462-72. PubMed ID: 21761573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Linkage analysis in a Japanese long QT syndrome family].
    Akimoto K; Matsuoka R; Kasanuki H; Takao A; Monma K; Hayakawa K; Hosoda S
    Kokyu To Junkan; 1993 May; 41(5):463-5. PubMed ID: 8484055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease.
    Davis RP; Casini S; van den Berg CW; Hoekstra M; Remme CA; Dambrot C; Salvatori D; Oostwaard DW; Wilde AA; Bezzina CR; Verkerk AO; Freund C; Mummery CL
    Circulation; 2012 Jun; 125(25):3079-91. PubMed ID: 22647976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular genetics of the long QT syndrome: clinical aspects].
    Sepp R; Csanády M
    Orv Hetil; 1999 Nov; 140(47):2633-8. PubMed ID: 10613047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotype-Based High-Throughput Classification of Long QT Syndrome Subtypes Using Human Induced Pluripotent Stem Cells.
    Yoshinaga D; Baba S; Makiyama T; Shibata H; Hirata T; Akagi K; Matsuda K; Kohjitani H; Wuriyanghai Y; Umeda K; Yamamoto Y; Conklin BR; Horie M; Takita J; Heike T
    Stem Cell Reports; 2019 Aug; 13(2):394-404. PubMed ID: 31378668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.